Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis

Liu,Rong; Martin,Tracey   A.; Jordan,Nicola   J.; Ruge,Fiona; Ye,Lin; Jiang,Wen   G.

doi:10.3892/ijo.2015.3121

Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis

Authors:
- Rong Liu
- Tracey A. Martin
- Nicola J. Jordan
- Fiona Ruge
- Lin Ye
- Wen G. Jiang
View Affiliations

Affiliations: Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK
Published online on: August 13, 2015 https://doi.org/10.3892/ijo.2015.3121
Pages: 1429-1439

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metastasis suppressor 1 (MTSS1) is a potential metastasis suppressor gene involved in the regulation of cytoskeleton dynamics and subsequently in cell motility. MTSS1 expression is frequently reduced in a variety of cancer cells and tissues and this loss may account for increased invasive traits in cancer cells. The present study aimed to assess the role of MTSS1 in epithelial ovarian cancer (EOC) cells. Expression of MTSS1 in human ovarian cells was assessed at both the mRNA and protein levels using reverse transcription-PCR (RT-PCR) and immunohistochemistry, respectively. Full-length MTSS1 cDNA expression vector was used to generate MTSS1 overexpressing cells. The effect of MTSS1 overexpression on cellular functions was examined in EOC cells using a variety of in vitro assays. MTSS1 expression was observed both in ovarian cancer tissues and EOC cells. Over-expression of MTSS1 protein reduced the growth, invasion, adhesion and migration of EOC cell lines in vitro. The present study revealed that MTSS1 plays an essential inhibitory role in the development and progression of ovarian cancers. MTSS1 overexpression is intimately related to migration and metastasis, suggesting that MTSS1 is a potential prognostic marker and therapeutic molecular target in human ovarian cancer.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
3	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
4	Lee YG, Macoska JA, Korenchuk S and Pienta KJ: MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia. 4:291–294. 2002. View Article : Google Scholar : PubMed/NCBI
5	Nixdorf S, Grimm MO, Loberg R, Marreiros A, Russell PJ, Pienta KJ and Jackson P: Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines. Cancer Lett. 215:209–220. 2004. View Article : Google Scholar : PubMed/NCBI
6	Loberg RD, Neeley CK, Adam-Day LL, Fridman Y, St John LN, Nixdorf S, Jackson P, Kalikin LM and Pienta KJ: Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology. Int J Oncol. 26:1699–1705. 2005.PubMed/NCBI
7	Du P, Ye L, Li H, Yang Y and Jiang WG: The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway. J Exp Ther Oncol. 10:91–99. 2012.
8	Liu K, Wang G, Ding H, Chen Y, Yu G and Wang J: Downregulation of metastasis suppressor 1 (MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer. 10:4282010. View Article : Google Scholar
9	Parr C and Jiang WG: Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Eur J Cancer. 45:1673–1683. 2009. View Article : Google Scholar : PubMed/NCBI
10	Ma S, Guan XY, Lee TK and Chan KW: Clinicopathological significance of missing in metastasis B expression in hepato-cellular carcinoma. Hum Pathol. 38:1201–1206. 2007. View Article : Google Scholar : PubMed/NCBI
11	Yamagishi A, Masuda M, Ohki T, Onishi H and Mochizuki N: A novel actin bundling/filopodium-forming domain conserved in insulin receptor tyrosine kinase substrate p53 and missing in metastasis protein. J Biol Chem. 279:14929–14936. 2004. View Article : Google Scholar : PubMed/NCBI
12	Mattila PK, Salminen M, Yamashiro T and Lappalainen P: Mouse MIM, a tissue-specific regulator of cytoskeletal dynamics, interacts with ATP-actin monomers through its C-terminal WH2 domain. J Biol Chem. 278:8452–8459. 2003. View Article : Google Scholar
13	Woodings JA, Sharp SJ and Machesky LM: MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J. 371:463–471. 2003. View Article : Google Scholar : PubMed/NCBI
14	Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, Hernando E and Wei JJ: MiR182 overexpression in tumorigenesis of high-grade ovarian papillary serous carcinoma. J Pathol. 228:204–215. 2012. View Article : Google Scholar : PubMed/NCBI
15	Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD and Mansel RE: Expression of membrane type-1 matrix metal-loproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells. Int J Mol Med. 17:583–590. 2006.PubMed/NCBI
16	Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K and Mansel RE: Targeting matrilysin and its impact on tumor growth in vivo: The potential implications in breast cancer therapy. Clin Cancer Res. 11:6012–6019. 2005. View Article : Google Scholar : PubMed/NCBI
17	Jiang WG, Hiscox S, Singhrao SK, Nakamura T, Puntis MC and Hallett MB: Inhibition of HGF/SF-induced membrane ruffling and cell motility by transient elevation of cytosolic free Ca²⁺. Exp Cell Res. 220:424–433. 1995. View Article : Google Scholar : PubMed/NCBI
18	Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Scott C and Puntis MCA: Inhibition of invasion and motility of human colon cancer cells by gamma linolenic acid. Br J Cancer. 71:744–752. 1995. View Article : Google Scholar : PubMed/NCBI
19	Jiang WG, Martin TA, Lewis-Russell JM, Douglas-Jones A, Ye L and Mansel RE: Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer. 7:71–80. 2008. View Article : Google Scholar : PubMed/NCBI
20	Onda T and Yoshikawa H: Neoadjuvant chemotherapy for advanced ovarian cancer: Overview of outcomes and unanswered questions. Expert Rev Anticancer Ther. 11:1053–1067. 2011. View Article : Google Scholar : PubMed/NCBI
21	Kurman RJ, Visvanathan K, Roden R, Wu TC and Shih IeM: Early detection and treatment of ovarian cancer: Shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol. 198:351–356. 2008. View Article : Google Scholar : PubMed/NCBI
22	Yang JL, Ow KT, Russell PJ, Ham JM and Crowe PJ: Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors. Ann Surg Oncol. 3:574–579. 1996. View Article : Google Scholar : PubMed/NCBI
23	Goncharuk VN, del-Rosario A, Kren L, Anwar S, Sheehan CE, Carlson JA and Ross JS: Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. Ann Diagn Pathol. 8:6–16. 2004. View Article : Google Scholar : PubMed/NCBI
24	Mustafa N, Martin TA and Jiang WG: Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells. Exp Ther Med. 2:157–162. 2011.PubMed/NCBI
25	Dawson JC, Timpson P, Kalna G and Machesky LM: Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells. Oncogene. 31:1781–1793. 2012. View Article : Google Scholar
26	Xie F, Ye L, Chen J, Wu N, Zhang Z, Yang Y, Zhang L and Jiang WG: The impact of metastasis suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance. J Transl Med. 9:952011. View Article : Google Scholar : PubMed/NCBI
27	Dawson JC, Bruche S, Spence HJ, Braga VM and Machesky LM: Mtss1 promotes cell-cell junction assembly and stability through the small GTPase Rac1. PLoS One. 7:e311412012. View Article : Google Scholar : PubMed/NCBI
28	Fan H, Chen L, Zhang F, Quan Y, Su X, Qiu X, Zhao Z, Kong KL, Dong S, Song Y, Chan THM and Guan XY: MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma. Oncogene. 31:2298–2308. 2012. View Article : Google Scholar
29	Du P, Ye L, Ruge F, Yang Y and Jiang WG: Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer. Anticancer Res. 31:3205–3212. 2011.PubMed/NCBI
30	Callahan CA, Ofstad T, Horng L, Wang JK, Zhen HH, Coulombe PA and Oro AE: MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription. Genes Dev. 18:2724–2729. 2004. View Article : Google Scholar : PubMed/NCBI
31	Xie F, Ye L, Ta M, Zhang L and Jiang WG: MTSS1: A multi-functional protein and its role in cancer invasion and metastasis. Front Biosci (Schol Ed). 3:621–631. 2011. View Article : Google Scholar : PubMed/NCBI
32	Zhong J, Shaik S, Wan L, Tron AE, Wang Z, Sun L, Inuzuka H and Wei W: SCF β-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration. Oncotarget. 4:2339–2353. 2013. View Article : Google Scholar : PubMed/NCBI